Evidence map›Paper›PMID 34166426›Full record

Observational studyPloS one2021

Machine learning-based glucose prediction with use of continuous glucose and physical activity monitoring data: The Maastricht Study.

William P T M van Doorn, Yuri D Foreman, Nicolaas C Schaper, Hans H C M Savelberg, Annemarie Koster, Carla J H van der Kallen, Anke Wesselius, Miranda T Schram, Ronald M A Henry, Pieter C Dagnelie and 5 more

Registry-linked trialOpen access · goldAbstract readObservational Study
In one paragraph

Observational study in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07626658 (Food_i Sense Analytics), which is not on this map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
7.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07626658 not yet recruitingnot on this mapstarted 2026, after this paper: background citation

Food_i Sense Analytics: Integrando la Inteligencia Artificial Con la monitorización Continua de la Glucosa Para la nutrición de precisión

TypeobservationalSponsorIMDEA FoodRan2026 to 2028Enrolled471ConditionsPrediabetes (Insulin Resistance, Impaired Glucose Tolerance), Artificial Intelligence Mobile ApplicationArmsContinuous glucose monitoring using a wearable sensor (flash interstitial glucose monitor)
3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 91 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Exploring approaches to computational representation and classification of user-generated meal logs.Journal of the American Medical Informatics Association : JAMIA · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Composite activity type and stride-specific energy expenditure estimation model for thigh-worn accelerometry.The international journal of behavioral nutrition and physical activity · 2024
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

William P T M van DoornCARIM School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands.ORCID 0000-0003-2676-7448
Yuri D ForemanCARIM School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands.ORCID 0000-0002-0035-1586
Nicolaas C SchaperCARIM School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands.
Hans H C M SavelbergDepartment of Human Biology and Movement Science, NUTRIM School for Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, The Netherlands.
Annemarie KosterCAPHRI Care and Public Health Research Institute, Maastricht University, Maastricht, The Netherlands.
Carla J H van der KallenCARIM School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands.
Anke WesseliusDepartment of Complex Genetics and Epidemiology, NUTRIM School for Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, The Netherlands.
Miranda T SchramCARIM School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands.
Ronald M A HenryCARIM School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands.
Pieter C DagnelieCARIM School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands.
Bastiaan E de GalanCARIM School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands.
Otto BekersCARIM School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands.
Coen D A StehouwerCARIM School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands.
Steven J R MeexCARIM School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands.
Martijn C G J BrouwersCARIM School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands.
Maastricht University Medical Centre · NLMaastricht University · NLRadboud University Nijmegen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundClosed-loop insulin delivery systems, which integrate continuous glucose monitoring (CGM) and algorithms that continuously guide insulin dosing, have been shown to improve glycaemic control. The ability to predict future glucose values can further optimize such devices. In this study, we used machine learning to train models in predicting future glucose levels based on prior CGM and accelerometry data.

methodsWe used data from The Maastricht Study, an observational population-based cohort that comprises individuals with normal glucose metabolism, prediabetes, or type 2 diabetes. We included individuals who underwent >48h of CGM (n = 851), most of whom (n = 540) simultaneously wore an accelerometer to assess physical activity. A random subset of individuals was used to train models in predicting glucose levels at 15- and 60-minute intervals based on either CGM data or both CGM and accelerometer data. In the remaining individuals, model performance was evaluated with root-mean-square error (RMSE), Spearman's correlation coefficient (rho) and surveillance error grid. For a proof-of-concept translation, CGM-based prediction models were optimized and validated with the use of data from individuals with type 1 diabetes (OhioT1DM Dataset, n = 6).

resultsModels trained with CGM data were able to accurately predict glucose values at 15 (RMSE: 0.19mmol/L; rho: 0.96) and 60 minutes (RMSE: 0.59mmol/L, rho: 0.72). Model performance was comparable in individuals with type 2 diabetes. Incorporation of accelerometer data only slightly improved prediction. The error grid results indicated that model predictions were clinically safe (15 min: >99%, 60 min >98%). Our prediction models translated well to individuals with type 1 diabetes, which is reflected by high accuracy (RMSEs for 15 and 60 minutes of 0.43 and 1.73 mmol/L, respectively) and clinical safety (15 min: >99%, 60 min: >91%).

conclusionsMachine learning-based models are able to accurately and safely predict glucose values at 15- and 60-minute intervals based on CGM data only. Future research should further optimize the models for implementation in closed-loop insulin delivery systems.

Indexed as

ExerciseMachine LearningAdultAgedAlgorithmsBlood GlucoseCase-Control StudiesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2FemaleHumansMaleMiddle AgedMonitoring, AmbulatoryNeural Networks, ComputerPrediabetic StateBlood Glucose

Identifiers

PMID34166426
PMCPMC8224858
OpenAlexW3175738155

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.